Howard W Robin
CEO, President at Nektar Therapeutics (NKTR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 20SEC | NKTRNektar Therapeutics | Sell | 41854,627 held (−1%) | $71.98 | $30K | -42.8% |
| Jun 18SEC | NKTRNektar Therapeutics | Sell Plan | 5,30369,742 held (−7%) | $59.97 | $318K | -31.3% |
| Jun 18SEC | NKTRNektar Therapeutics | Sell Plan | 4,69765,045 held (−7%) | $60.71 | $285K | -32.2% |
| Jun 18SEC | NKTRNektar Therapeutics | Sell Plan | 5,50059,545 held (−8%) | $60.81 | $334K | -32.3% |
| Jun 18SEC | NKTRNektar Therapeutics | Sell Plan | 4,50055,045 held (−8%) | $61.65 | $277K | -33.2% |
| May 21SEC | NKTRNektar Therapeutics | Sell | 44475,045 held (−1%) | $65.51 | $29K | -37.2% |
| Feb 20SEC | NKTRNektar Therapeutics | Sell | 42375,489 held (−1%) | $73.00 | $31K | -43.6% |
| Nov 25SEC | NKTRNektar Therapeutics | Sell | 2,20754,245 held (−4%) | $54.28 | $120K | -24.2% |
- Sell
CEO, President Howard W Robin sold $318K of NKTR at $59.97 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Howard W Robin sold $285K of NKTR at $60.71 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Howard W Robin sold $334K of NKTR at $60.81 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Howard W Robin sold $277K of NKTR at $61.65 — pre-scheduled 10b5-1 plan sale.